Table 4 Treatment-emergent adverse events* during 24 months of miglustat therapy (all-enrolled population)
Adverse event | Incidence (N = 42) | |
|---|---|---|
| Â | n | % |
Diarrhea | 31 | 31 (74) |
Flatulence | 21 | 21 (50) |
Tremor | 15 | 15 (36) |
Headache | 9 | 9 (21) |
Paresthesia | 9 | 9 (21) |
Fatigue | 8 | 8 (19) |
Dizziness | 7 | 7 (17) |
Arthralgia | 6 | 6 (14) |
Weight decreased | 6 | 6 (14) |
Abdominal discomfort | 5 | 5 (12) |
Hypoesthesia | 5 | 5 (12) |